In this phase IV trial, the authors assessed antibody responses to multiple vaccines in the same individuals of different age groups and show that the responsiveness to different vaccines was highly variable but that a small group of older male adults responded low to multiple vaccines.
Reviewer recognition:
- Marieke van der Heiden
- Sudarshan Shetty
- Debbie van Baarle
